Larmon JE, Magann EF, Dickerson GA, Morrison JC. Outpatient cervical ripening withprostaglandin E2 and estradiol. J Matern Fetal Neona 2002;11(2):113-7.Laros RK Jr, Work BA Jr, Witting WC. Amniotomy <strong>du</strong>ring the active phase of labor. ObstetGynecol 1972;39(5):702-4.Larson EB, van Belle G, Shy KK, Luthy DA, Strickland D, Hughes JP. Fetal monitoring andpredictions by clinicians: Observations <strong>du</strong>ring a randomized clinical trial in very lowbirth weight infants. Obstet Gynecol 1989;74(4):584-9.Lavender T, Hofmeyr GJ, Neilson JP, Kingdon C, Gyte GM. Caesarean section for non-medicalreasons at term. Cochrane Database Syst Rev 2012;3:CD004660.Leighton BL et Halpern SH. Epi<strong>du</strong>ral analgesia and the progress of labour. Dans : Halpern SH etDouglas MJ, réd. Evidence-based obstetric anesthesia. Oxford, Royaume-Uni :Blackwell; 2005 : 10-22.Leighton BL et Halpern SH. The effects of epi<strong>du</strong>ral analgesia on labor, maternal, and neonataloutcomes: A systematic review. Am J Obstet Gynecol 2002;186(5 Suppl Nature):S69-77.Leijon I, Finnström O, Hedenskog S, Rydén G, Tylleskär J. Spontaneous labor and electivein<strong>du</strong>ction—A prospective randomized study. II. Bilirubin levels in the neonatal period.Acta Obstet Gynecol Scand 1980;59(2):103-6.Leijon I, Finnström O, Hedenskog S, Rydén G, Tylleskär J. Spontaneous labour and electivein<strong>du</strong>ction—A prospective randomized study. Behavioural assessment and neurologicalexamination in the newborn period. Acta Paediatr Scand 1979;68(4):553-60.Leveno KJ, Cunningham FG, Nelson S, Roark M, Williams ML, Guzick D, et al. A prospectivecomparison of selective and universal electronic fetal monitoring in 34,995 pregnancies.N Engl J Med 1986;315(10):615-9.Lewis GJ. Cervical ripening before in<strong>du</strong>ction of labour with prostaglandin E2 pessaries or aFoley's catheter. J Obstet Gynaecol 1983;3:173-6.Lian Q et Ye X. The effects of neuraxial analgesia of combination of ropivacaine and fentanyl onuterine contraction. Anesthesiology 2008;109:A1332. Disponible à :http://www.asaabstracts.com/strands/asaabstracts/search.htm;jsessionid=7EE81F19D70172629B9B45209DB7276E.Lieberman E et O'Donoghue C. Unintended effects of epi<strong>du</strong>ral analgesia <strong>du</strong>ring labor: Asystematic review. Am J Obstet Gynecol 2002;186(5 Suppl Nature):S31-68.Lien JM, Morgan MA, Garite TJ, Kennedy KA, Sassoon DA, Freeman RK. Antepartum cervicalripening: applying prostaglandin E2 gel in conjunction with sche<strong>du</strong>led nonstress tests inpostdate pregnancies. Am J Obstet Gynecol 1998;179(2):453-8.Lin MG, Nuthalapaty FS, Carver AR, Case AS, Ramsey PS. Misoprostol for labor in<strong>du</strong>ction inwomen with term premature rupture of membranes: A meta-analysis. Obstet Gynecol2005;106(3):593-601.180
Liston R, Sawchuck D, Young D. Surveillance <strong>du</strong> bien-être foetal : directive consensusd'antepartum et intrapartum. J Obstet Gynaecol Can 2007;29(9 Supp 4):S3-S64.Liu EH et Sia AT. Rates of caesarean section and instrumental vaginal delivery in nulliparouswomen after low concentration epi<strong>du</strong>ral infusions or opioid analgesia: Systematic review.BMJ 2004;328(7453):1410.Lo JY, Alexander JM, McIntire DD, Leveno KJ. Ruptured membranes at term: Randomized,double-blind trial of oral misoprostol for labor in<strong>du</strong>ction. Obstet Gynecol2003;101(4):685-9.Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J. Opinion leaders vs audit andfeedback to implement practice guidelines. Delivery after previous cesarean section.JAMA 1991;265(17):2202-7.Long J et Yue Y. Patient controlled intravenous analgesia with tramadol for labor pain relief.Chin Med J (Engl) 2003;116(11):1752-5.Lopez-Zeno JA, Peaceman AM, Adashek JA, Socol ML. A controlled trial of a program for theactive management of labor. N Engl J Med 1992;326(7):450-4.Loughnan BA, Carli F, Romney M, Dore CJ, Gordon H. Randomized controlled comparison ofepi<strong>du</strong>ral bupivacaine versus pethidine for analgesia in labour. Br J Anaesth2000;84(6):715-9.Lucas MJ, Sharma SK, McIntire DD, Wiley J, Sidawi JE, Ramin SM, et al. A randomized trial oflabor analgesia in women with pregnancy-in<strong>du</strong>ced hypertension. Am J Obstet Gynecol2001;185(4):970-5.Luthy DA, Shy KK, van Belle G, Larson EB, Hughes JP, Benedetti TJ, et al. A randomized trialof electronic fetal monitoring in preterm labor. Obstet Gynecol 1987;69(5):687-95.Lyons C, Rumney P, Huang W, Morrison E, Thomas S, Nageotte M, Asrat T. Outpatient cervicalripening with oral misoprostol postterm: In<strong>du</strong>ction rates re<strong>du</strong>ced. Am J Obstet Gynecol2001;184(1):S116.Ma W, Bai W, Lin C, Zhou P, Xia L, Zhao C, et al. Effects of Sanyinjiao (SP6) withelectroacupuncture on labour pain in women <strong>du</strong>ring labour. Complement Ther Med2011;19(Suppl 1):S13-8.MacDonald D, Grant A, Sheridan-Pereira M, Boylan P, Chalmers I. The Dublin randomizedcontrolled trial of intrapartum fetal heart rate monitoring. Am J Obstet Gynecol1985;152(5):524-39.MacKenzie IZ et Embrey MP. A comparison of PGE2 and PGF2 alpha vaginal gel for ripeningthe cervix before in<strong>du</strong>ction of labour. Br J Obstet Gynaecol 1979;86(3):167-70.Mackenzie IZ, Xu J, Cusick C, Midwinter-Morten H, Meacher H, Mollison J, Brock M.Acupuncture for pain relief <strong>du</strong>ring in<strong>du</strong>ced labour in nulliparae: A randomised controlledstudy. BJOG 2011;118(4):440-7.181
- Page 1 and 2:
ANNEXES DU RAPPORTMesures prometteu
- Page 3 and 4:
Tableau B-6 Les études cliniques i
- Page 5 and 6:
PubMedSURVEILLANCE FŒTALE ÉLECTRO
- Page 7 and 8:
PubMedACCÉLÉRATION DU TRAVAILRech
- Page 9 and 10:
De plus, en utilisant les mêmes co
- Page 11:
Tableau B-2b Les essais cliniques r
- Page 14 and 15:
Evron, 2007Shifman, 2007Nafisi, 200
- Page 16 and 17:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 18 and 19:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 20 and 21:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 22 and 23:
Tableau B-7 Les études cliniques i
- Page 24 and 25:
Thurnau, 1991 (P)xPickhardt, 1992 (
- Page 26 and 27:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 28 and 29:
REVUESSYSTÉMATIQUESLiu et Sia, 200
- Page 30 and 31:
Tableau C-4 La description des revu
- Page 32 and 33:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 34 and 35:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 36 and 37:
REVUESSYSTÉMATIQUESWei, 2009aCanad
- Page 38 and 39:
Tableau C-6 La description des revu
- Page 40 and 41:
Tableau C-7 La description des revu
- Page 42 and 43:
REVUESSYSTÉMATIQUESKhunpradit, 201
- Page 44 and 45:
ANNEXE D CARACTÉRISTIQUES DES ÉTU
- Page 46 and 47:
REVUESSYSTÉMATIQUESHowarth et Bota
- Page 48 and 49:
ANNEXE E RECENSEMENT DES ÉLÉMENTS
- Page 50 and 51:
Conditions INTRApartum jamaisinclus
- Page 52 and 53:
ANNEXE F EXERCICES D’INTERPRÉTAT
- Page 54 and 55:
F.1 ANALGÉSIE PÉRIDURALEF.1.1 EXE
- Page 56 and 57:
3. Les implications sur la pratique
- Page 58 and 59:
5. Les enjeux éthiquesPeut-il y av
- Page 60 and 61:
F.1.2 SOMMAIRE DES COMMENTAIRES RE
- Page 62 and 63:
Question 3Les implications sur la p
- Page 64 and 65:
Question 4Facilitateurs pour les al
- Page 66 and 67:
Éléments de mesureConcernant la p
- Page 68 and 69:
F.2 SURVEILLANCE FŒTALE ÉLECTRONI
- Page 70 and 71:
4. Les implications sur la pratique
- Page 72 and 73:
6. Les enjeux éthiquesSi on vous d
- Page 74 and 75:
ENCERCLEZ les conditions antepartum
- Page 76 and 77:
Évaluation de l’exerciceMerci d
- Page 78 and 79:
Question 3Facteurs liés à la non-
- Page 80 and 81:
Question 5Avantages et inconvénien
- Page 82 and 83:
Question 6Arguments de nature éthi
- Page 84 and 85:
Éléments de mesuresConcernant la
- Page 86 and 87:
F.3 DÉCLENCHEMENT ET ACCÉLÉRATIO
- Page 88 and 89:
3. Des mesures pour optimiser le re
- Page 90 and 91:
Évaluation de l’exerciceMerci d
- Page 92 and 93:
Éviter l’analgésie périduralee
- Page 94 and 95:
péridurale.Manque de préparation
- Page 96 and 97:
Considérant que le déclenchement
- Page 98 and 99:
4. Les enjeux éthiquesIniquités d
- Page 100 and 101:
F.4 CÉSARIENNEF.4.1 EXERCICE D’I
- Page 102 and 103:
3. Les implications sur la pratique
- Page 104 and 105:
5. Les enjeux éthiquesIniquités d
- Page 106 and 107:
F.4.2 SOMMAIRE DES COMMENTAIRES RE
- Page 108 and 109:
Question 3Les implications sur la p
- Page 110 and 111:
Question 4Facilitateurs et barrièr
- Page 112 and 113:
Éléments pour mesures (spécifiqu
- Page 114 and 115:
ANNEXE G TRAVAUX AVEC LE COMITÉ DE
- Page 116 and 117:
Programme9 h 30-10 h 00 Accueil et
- Page 118 and 119:
OUTIL DE CONSULTATION1. Cotez de 1
- Page 120 and 121:
accompagnant spécialement formé
- Page 122 and 123:
PertinenceAcceptabilitéFaisabilit
- Page 124 and 125:
PertinenceAcceptabilitéFaisabilit
- Page 126 and 127:
PertinenceAcceptabilitéFaisabilit
- Page 128 and 129:
Bloc 2 : la surveillance fœtale é
- Page 130 and 131:
PertinenceAcceptabilitéFaisabilit
- Page 132 and 133:
PertinenceAcceptabilitéFaisabilit
- Page 134 and 135: La surveillance fœtale électroniq
- Page 136 and 137: Dans les grossesses à terme et à
- Page 138 and 139: PertinenceAcceptabilitéFaisabilit
- Page 140 and 141: Considérant que l’accélération
- Page 142 and 143: 19691987200120062009Bloc 4 : la cé
- Page 144 and 145: Contribution au taux général de c
- Page 146 and 147: (2001) et de diffuser périodiqueme
- Page 148 and 149: Mesures pour réduire le recours à
- Page 150 and 151: La césarienne2. Suggestions pour d
- Page 152 and 153: culture de la naissance. C’est au
- Page 154 and 155: contrer la tendance à recourir aux
- Page 156 and 157: FACTEURS ASSOCIÉS : Sensibiliser l
- Page 158 and 159: 154- (ce libellé est) contre-produ
- Page 160 and 161: BLOC 3 - Déclenchement / accélér
- Page 162 and 163: BLOC 4 - CésarienneGÉNÉRAL - MIS
- Page 164 and 165: FACTEURS ASSOCIÉS - GÉNÉRAL : Fa
- Page 166 and 167: Ocytocine pour déclenchement du tr
- Page 168 and 169: Support 1 : 1 (Hodnett, 2011)Nombre
- Page 170 and 171: Anim-Somuah M, Smyth RM, Jones L. E
- Page 172 and 173: Bugg GJ, Siddiqui F, Thornton JG. O
- Page 174 and 175: Cogan R et Spinnato JA. Social supp
- Page 176 and 177: El-Torkey M et Grant JM. Sweeping o
- Page 178 and 179: Gourounti K et Sandall J. Admission
- Page 180 and 181: Hauth JC, Cunningham FG, Whalley PJ
- Page 182 and 183: Huang XH, Xiang XY, Shen RG, Shang
- Page 186 and 187: MacKenzie IZ, Bradley S, Embrey MP.
- Page 188 and 189: Morales WJ et Lazar AJ. Expectant m
- Page 190 and 191: Ozden S, Delikara MN, Avci A, Ficic
- Page 192 and 193: Roberts WE, North DH, Speed JE, Mar
- Page 194 and 195: Shifman EM, Butrov AV, Floka SE, Go
- Page 196 and 197: Thorp JA, Hu DH, Albin RM, McNitt J
- Page 198: Witoonpanich P et Surapong K. Contr